Correlation Between Acrivon Therapeutics, and Erasca
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Erasca at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Erasca into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Erasca Inc, you can compare the effects of market volatilities on Acrivon Therapeutics, and Erasca and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Erasca. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Erasca.
Diversification Opportunities for Acrivon Therapeutics, and Erasca
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Acrivon and Erasca is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Erasca Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erasca Inc and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Erasca. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erasca Inc has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Erasca go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Erasca
Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to under-perform the Erasca. In addition to that, Acrivon Therapeutics, is 1.21 times more volatile than Erasca Inc. It trades about -0.08 of its total potential returns per unit of risk. Erasca Inc is currently generating about 0.08 per unit of volatility. If you would invest 264.00 in Erasca Inc on August 29, 2024 and sell it today you would earn a total of 14.00 from holding Erasca Inc or generate 5.3% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Erasca Inc
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Erasca Inc |
Acrivon Therapeutics, and Erasca Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Erasca
The main advantage of trading using opposite Acrivon Therapeutics, and Erasca positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Erasca can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erasca will offset losses from the drop in Erasca's long position.| Acrivon Therapeutics, vs. Eliem Therapeutics | Acrivon Therapeutics, vs. Scpharmaceuticals | Acrivon Therapeutics, vs. Milestone Pharmaceuticals | Acrivon Therapeutics, vs. Seres Therapeutics |
| Erasca vs. Eliem Therapeutics | Erasca vs. Scpharmaceuticals | Erasca vs. Milestone Pharmaceuticals | Erasca vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |